Home

Canadian Government Funds Alzheimers Research

Wed, 09/13/2000 - 12:00am — Karen Stevenson
Description: 

A collaborative effort between the Alzheimer Society of Canada, AstraZeneca Canada Inc., AstraZeneca US and the Canadian Institutes of Health Research (CIHR) through its partnership with Canada's Research-Based Pharmaceutical Companies (Rx&D) will help generate new research into Alzheimer Disease. The Alzheimer Disease Research Grants Program is designed to stimulate individual Canadian investigators to undertake innovative research into the cause and cure of Alzheimer Disease. The Program offers up to four biomedical research grants focussed on the causes, diagnosis and treatment of Alzheimer Disease for each of two years. Researchers are invited to submit proposals designed to yield new insights into the prevention and treatment of Alzheimer Disease. Applications for up to $100,000/annum for projects of up to two years will be considered.

A collaborative effort between the Alzheimer Society of Canada, AstraZeneca Canada Inc., AstraZeneca US and the Canadian Institutes of Health Research (CIHR) through its partnership with Canada's Research-Based Pharmaceutical Companies (Rx&D) will help generate new research into Alzheimer Disease. The Alzheimer Disease Research Grants Program is designed to stimulate individual Canadian investigators to undertake innovative research into the cause and cure of Alzheimer Disease. The Program offers up to four biomedical research grants focussed on the causes, diagnosis and treatment of Alzheimer Disease for each of two years. Researchers are invited to submit proposals designed to yield new insights into the prevention and treatment of Alzheimer Disease. Applications for up to $100,000/annum for projects of up to two years will be considered.